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CARCINOMA IN SITU OF THE URINARY BLADDER 
Report of a Case 
CHARLES F . PE.\RCE, M.D.,* AND ARTHUR J. JOHNSON, M.D.* 
Cancer of the bladder is the most important of the malignant tumors of the 
urinary organs. In 1950, the Pubhc Health Service reported that 177,464 persons in 
the United States died of malignant disease during 1945; of these, 5,410, or 3% of 
the total, died from bladder cancer. Per 100,000 population in 1945, the death rate 
from bladder cancer among persons 55 to 64 years of age was 10.5; among those 
65 to 74 years old it was 26.2 and among persons 75 to 84 it has risen to 49.4. 
The ratio of male to female is 4 to 1.^  
CASE HISTORY 
A 62-year-old white male first presented to the Urology Clinic in 1961 with 
irritative bladder symptoms. He gave a history of having had a transurethral resection 
for benign prostatic hypertrophy elsewhere. The patient did not respond to anti-
spasmodics; his urine was not infected. In January 1962 he was endoscoped and 
was found to have some residual anterior tissue. This was resected. He did well 
following this resection with no irritative symptoms and with good size and force 
to stream. 
In May 1963 he again presented with irritative symptoms. A number 22F sound 
passed into the bladder with ease. The patient was placed on Levamine. His urine 
was uninfected. 
In January 1964 he presented to the clinic with the history of having a few 
flecks of blood in his urine. 
In March 1964 the patient was cystoscoped. A diffuse erythema was noted 
especially on the left of the trigone. Retrograde pyelograms were normal. A biopsy 
with a resectoscope was made and the pathology report was carcinoma in situ. 
The patient was recystoscoped in June 1964. Some reddening of the entire left 
side of the trigone, and scarring from the previous biopsy were noted. 
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In September 1964 the patient had another cystoscopic examination and was 
almost asymptomatic at this time. Again a slightly red heaped-up area on the left 
side of the trigone was noted. A transurethral resection of this area was performed. 
The pathology report was carcinoma in situ, and the ressction was followed by four 
treatments with Thio-topa. 
In January 1965 cystoscopy again showed a reddened elevated lesion on the 
trigone, spreading across the midline. This area was resected and the pathology 
report was again carcinoma in situ. Prior to this examination, the patient did not 
have any red blood cells in his urine. 
In March 1965 a reddened area on the left side of the trigone was again noted 
with question of a cyst formation. Intravenous pyelograms were normal. 
The patient was admitted to the hospital in April 1965 and had another trans-
urethral resection of this area. The pathology report was transitional cell carcinoma 
with superficial invasion. Several reddened areas above the trigone were noted on 
this cystoscopy. 
In June 1965 the patient had a cystectomy and ileac conduit. His postoperative 
course was uneventful and at present he is doing well with no evidence of metastatic 
or residual tumor. 
Figure 1 
Carcinoma in situ of the urinary bladder 175x. 
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Figure 2 
Carcinoma in situ of the urinary bladder 840x. 
Figure 3 
Transitional cell carcinoma of the bladder showing superficial invasion 175x. 
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Figure 4 
Transitional cell carcinoma of the bladder showing superficial invasion 840x. 
DISCUSSION 
Because of their biologic characteristics, all papUlary, fungating epithelial tumors 
should be called carcinoma, even those that appear histologically well-differentiated 
and apparently benign. Very well-differentiated forms recur, invade and have aggres-
siveness. These tumors provide a classic example of the necessity for a specific 
knowledge of the hfe history of all forms of neoplasia since in different locations 
essentially similar lesions may ha,ve totally dissimilar behavior. 
The great majority of bladder tumors are epithelial. The term noninfiltrating 
implies that the basement membrane is intact beneath the tumor. When tumor cells 
break through this membrane the tumor becomes infiltrating. In the Brady Urological 
Institute, 33% of the epithelial tumors were found by Scott and McKay' to be non-
infiltrating when first seen. Most of these tumors were papillomas. 
A noninvasive sessile carcinoma is called intraepithelial carcinoma or carcinoma 
in situ. The tumor has no pedicle, but its epithelium exhibits a variable degree of 
pleomorphism. Anaplasia, hyperchromatism, polynucleosis, disparity in size, shape, 
and staining quality of nuclei, increase in abnormal mitosis, and disorderly arrange-
ment of the cells are frequently observed, but the basement membrane is intact. The 
multilayering of the epithelial cells, however, is not itself an indication of malignancy; 
pleomorphism, on the other hand, does indicate malignancy. 
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In 1922 Broderi attempted to relate prognosis of bladder tumors to differentiation 
of the cells from normal mature epithelium. However, in 1951 at Johns Hopkins 
Hospital it was demonstrated in a study of 95 cases that approximately 45% showed 
degrees of cellular differentiation in different parts of the same tumor. 
In 1946, Jewett^  studied 107 autopsy cases of bladder carcinoma with regard to 
the incidence of metastases, e.g. regional and distal metastases, the number showing 
perivesical lymphatic or vascular invasion only, and the number with perivesical 
fixation of the mass. The percentage of cases without these evidences of tumor spread 
gives us our figure of potential curability: 
Group A, submucosal infiltration, 100% potential curability. 
Group B, muscular infiltration, 86.6% potential curability. 
Group C, perivesical infiltration, 26% potential curability. 
Powell showed that the lymphatics are larger and more numerous in the depths 
of the bladder wall, which may explain the higher incidence of metastases in Group 
C tumors. 
The incidence of metastases and extravesical extension therefore varied directly 
with the depth to which the tumor had infiltrated the wall of the bladder. 
MarshalP studied 106 patients treated with excision and fulgeration. The overall 
five-year survival rate was 69.8%. The stage and grade of tumor affected survival. 
Consequently, the five-year survival rate was 82% in patients with low stage, low 
grade tumor, 76% in patients with low stage, high grade tumor, 16.7% in patients 
with high stage, high grade tumor, 0% in (2) patients with high stage, low grade tumor. 
Marshall concluded that the low grade and low stage carcinomas of the urinary 
bladder were reasonably well managed by local excision and fulgeration, together 
with careful follow-up cystoscopic examinations. The operative risk was low; the 
morbidity was not great; continence was maintained; and most particularly the 
survival closely approximated the expectancy otherwise. In contrast, cancers of high 
grade malignancy, especially those in high stages were not satisfactorily controlled by 
local excision and fulgeration. 
Marshall and Whitmore'' made several conclusions from their study of bladder 
tumors. Some of those concerning low grade low stage tumors are as follows: 
1. The most powerful influence on the patient's course is the intrinsic nature 
of the neoplasm. 
2. Initial treatment of choice, for patients with low grade carcinoma still in low 
stages, is local excision, fulguration and follow-up. 
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3. High grade carcinoma in low stages is also probably best managed by local 
excision, fulguration, and follow-up as the initial therapy. But close follow-up is 
required as a change of therapy will often be indicated. 
As can be seen from the above, the survival rate from carcinoma of the bladder 
decreases as the stage increases. Carcinoma in situ is an entity by itself, that must be 
recognized, and a knowledge of its life history will determine the aggressiveness of 
the surgical approach. 
Voutsa and Melamed' in studying the cytology of in situ carcinoma of the 
urinary bladder followed 20 patients for six years. All patients had a past history 
of apparently successfully treated and eradicated benign papilloma or carcinoma. 
Cytological specimens were obtained in a follow-up period. 
Papanicolaou stained smears of urinary sediment were studied — 350 specimens 
were examined in the 20 patients. In all cases, patients had specimens taken at the 
time when they had in situ carcinoma as well as could be determined clinically, 
cystoscopically, and pathologically. 
Six cases showed progress from in situ to invasive carcinoma. In 6 patients 
who had a total cystectomy a diagnosis of in situ carcinoma without invasion could be 
confirmed by pathological study of the entire bladder. Of 8 patients remaining, 6 still 
have in situ carcinoma. Two died of unrelated disease without evidence of invasion. 
The histological diagnosis of in situ carcinoma is based on apprasial of cytological 
alterations in sections of epithelium. Cytological diagnosis in smears rests on recognition 
of these same alterations in cells exfoliated from the epithelial surface. 
The most consistent and most characteristic picture of the cytological presenta-
tion was a uniform pattern of malignant cells seldom seen in invasive carcinoma. 
Cells were found singly or in small clusters and could be numerous or few. Alterations 
within the cells were less bizarre and less obvious than in invasive carcinoma. In 
carcinoma in situ, cells were about the size of normal bladder epithelial cells or a 
little larger. 
The nuclei were slightly enlarged, always hyperchromatic with coarse chromatic 
structure. The cytoplasm was usually thin and moderate in amount, and often showed 
a hazy opacity usually not seen in benign bladder epithelial cells. 
The results of their study was that a cytological pattern does exist in carcinoma 
in situ which is different from that of invasive carcinoma. 
Meiicow' in 1952 studied ten total cystectomy tumor-bearing and five control 
tumor-free bladders. Routine sections of the tumor and of pieces of normal looking 
mucosa were made. 
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In two of the tumor-bearing bladders, areas of carcinoma in situ were found 
on section of the normal-appearing mucosa. Epithehal hyperplasia, cystitis cystica 
and glandularis were found on the other tumor-bearing bladders studied. In two of 
the bladders which showed hyperplasia, hyperchromatism was also noted. Of the 
five normal bladders studied, one with cystitis cystica was found. 
The findings suggest that in any operation upon the bladder for the removal 
of a grossly obvious growth, there may already be present in that bladder, unseen 
with the naked eye, areas of hyperplasia or beginning anaplasia or both; these in 
time could result in gross new tumor formation. Many recurrences therefore are 
actually the coming of age symptomatically of a neoplastic process which may have 
been initiated before or after operation. 
Meiicow found that bladders which contained papillary tumors, single or multiple, 
showed a greater incidence of microscopic foci of epithelial activity than did solid 
solitary tumors. This conforms with the clinical observation that many of the 
papillary tumors may first spread in a horizontal plane while the indurated and 
ulcerative types penetrate earlier in a vertical plane into the muscularis. I t has also 
been observed that papillary tumors are often multiple when initially seen. 
Brunn's nests in association with bladder tumors have been noted by many 
authors. Little attention has been given to the analogous association of other pro-
liferative lesions. 
Proliferative bladder lesions may be classified as: 
1. Cystitis cystica. 
2. Atypical hyperplasia. 
3. Papillary hyperplasia. 
4. Intraepithelial epithelioma (in situ carcinoma). 
Eisenberg' made 171 consecutive bladder biopsies from bladders which con-
tained overt tumors. The specimens were carefully examined for the occurrence of 
proMferative lesions of the type just described occurring in bladder mucosa distant 
from the immediate field of the overt tumors. He found that focal mucosal lesions 
of a proliferative nature with cellular atypism and abnormality of pattern frequently 
accompany overt bladder tumors, and demonstrated them in mucosa in approximately 
30% of the infiltrating tumors studied. These focal lesions (such as in situ carcinoma) 
occur synchronously with the overt tumors, but the possibility remains that they 
might precede clinically manifest tumors. 
Clinical correlations in a rigidly selected, fully followed group of 24 patients 
showed that in no case which progressed for five or more years in wholly satisfactory 
fashion were such lesions initially present. Whereas, in all cases with unsatisfactory 
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progress these lesions could be demonstrated. The suggestion is made that the presence 
or absence of these associated proliferative mucosal lesions is an ascertainable physical 
feature of bladder tumor formation which may have considerable prognostic signi-
ficance. 
L. N . Pyrah" of Leeds University studied 365 cases of papilloma and 139 cases 
of papillary tumors showing carcinoma (carcinoma in situ) of the bladder. The sex 
ration male to female was 3.8 to 1 for carcinoma in situ. It was 2.9 to 1 for 
papilloma. The proportion of multiple to single tumors was higher in the carcinoma 
in situ group: 36% as compared to 25% in the papilloma group. 
Most carcinoma in situ tumors were treated similarly to papillomas with fulgurative 
transurethral resection and suprapubic loop excision. Approximately 33%, however, 
were treated with more radical methods. Of patients with carcinoma in situ 36.4% 
underwent a second phase of treatment within the first year, compared with 20% 
in the papilloma group. In 7% of cases of papilloma an invasive cancer supervened, 
often after many years. 
The death rate from invasive cancer in all cases originally diagnosed as papilloma 
is 6%. Death occurred at not less than five years and up to sixteen years following 
the initial diagnosis of papilloma. 
The death rate from invasive cancer in all cases originally diagnosed as early 
carcinoma or carcinoma in situ is 7.9%, death frequently occurring in less than 
three years. Thus, it appears that death from invasive cancer occurs sooner in the 
early carcinoma group than in the papilloma group, although in other respects the 
two are similar. 
Austin' studied 12 total cystectomy bladders removed for tumor. Proliferative 
mucosal lesions of one variety or another were seen in all cases, confirming the 
findings of Meiicow. 
Al l 12 bladders showed diffuse atypical mucosal changes ranging through the 
entire pathologic spectrum. Four bladder specimens were found to contain grossly 
undetectable carcinoma in situ in the bladder far removed from the principal tumor. 
In two other cases, carcinoma in situ was discovered in the intramural distal end 
of a ureter and distant from the primary lesion. 
In summary, it may be said that carcinoma in situ or intraepithelial carcinoma 
of the urinary bladder presents a perplexing problem to the urologist. When more 
tumors of this type are studied, definitive types of therapy may be determined. 
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